Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
Open accessThe DOI matches its Crossref record; 244 of the 246 references it cites were found in a registry or an index.
Abstract
Background.: Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (tuberculosis disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). Tuberculosis disease is a leading cause of infectious disease morbidity and mortality worldwide, yet many questions related to its diagnosis remain. Methods.: A task force supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America searched, selected, and synthesized relevant evidence. The evidence was then used as the basis for recommendations about the diagnosis of tuberculosis disease and LTBI in adults and children. The recommendations were formulated, written, and graded using the Grading, Recommendations, Assessment, Development and Evaluation (GRADE) approach. Results.: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided. Six of the recommendations are strong, whereas the remaining 17 are conditional. Conclusions.: These guidelines are not intended to impose a standard of care. They provide the basis for rational decisions in the diagnosis of tuberculosis in the context of the existing evidence. No guidelines can take into account all of the often compelling unique individual clinical circumstances.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, culture may lead to misclassification of some cases of extrapulmonary tuberculosis as ‘not tuberculosis', owing to the paucibacillary nature of the disease.”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“This means that culture may have low sensitivity for extrapulmonary tuberculosis overall and further that culture sensitivity may differ for different forms of extrapulmonary tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“A recent evidence synthesis reported sensitivities of 72% to 88% in lymph node tissue, 28% to 81% in pleural fluid, 90% in pleural tissue, and 31% to 56% in CSF. Specificity ranged from 90% to 100% (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
In the citing paper
“For the 'Summary of findings' tables for CSF and pleural fluid, we provide evidence using culture as the reference standard, which is considered the best reference standard for tuberculosis (Lewinsohn 2017).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Lewinsohn 2017
Citations
Cites
Items 201–244 of 244
Feasibility of Shortening Respiratory Isolation with a Single Sputum Nucleic Acid Amplification Test
Campos, M., Quartin, A. A., Mendes, E. S., Abreu, A. R., Gurevich, S., Echarte, L., Ferreira, T., Cleary, T., Hollender, E. S., & Ashkin, D. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-381oc · Cited by 36 · cited 1×
“men, some clinicians may find it beneficial in the diagnosis of individual patients [140, 141].”
BackgroundLeung, W. L., Law, K. L., Leung, V. S. S., Yip, C. W., Leung, C. C., Tam, C. M., & Kam, K. M. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00159-08 · Cited by 36
LoBue, P. A., & Ks, M. (2005) · PubMed · Cited by 35
Self-citationTuberculous Meningitis in an Urban General Hospital
Haas, E. J. (1977) · Archives of Internal Medicine · doi:10.1001/archinte.1977.03630230014007 · Cited by 35
Hinks, T., Dosanjh, D. P. S., Innes, J. A., Pasvol, G., Hackforth, S., Varia, H., Millington, K. A., Liu, X., Bakır, M., Soysal, A., et al. (2009) · Infection and Immunity · doi:10.1128/iai.01436-08 · Cited by 34
QuantiFERON®-TB Gold in the Diagnosis of Active Tuberculosis
Bártů, V., Havelková, M., & Kopecka, E. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600307 · Cited by 33
Latorre, I., de Souza-Galvão, M. L., Manzano, J. R., Lacoma, A., Prat, C., Fuenzalida, L., Altet, N., Ausina, V., & Domínguez, J. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.07.015 · Cited by 32
Reichler, M. R., Reves, R. R., Bur, S., et al. (2002) · Southern Medical Journal · doi:10.1097/00007611-200295040-00009 · Cited by 32
BOCK, N. N., Mallory, J. P., Mobley, N., DeVoe, B., & Taylor, B. B. (1998) · Clinical Infectious Diseases · doi:10.1086/514986 · Cited by 31
Comparison of performance in two diagnostic methods for tuberculosis infection
Higuchi, K., Kawabe, Y., Mitarai, S., Yoshiyama, T., Harada, N., & Mori, T. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-008-0102-5 · Cited by 31
Liao, C., Lai, C., Tan, C., Chou, C., Hsu, H.-L., Tasi, T.-N., Huang, Y., & Hsueh, P. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.012 · Cited by 30
Palme, I. B., Gudetta, B., Bruchfeld, J., Eriksson, M., & Giesecke, J. (2004) · Acta Paediatrica · doi:10.1111/j.1651-2227.2004.tb02953.x · Cited by 30
Kik, S. V., Franken, W. P. J., Arend, S. M., Mensen, M., Cobelens, F. G. J., Kamphorst, M., van Dissel, J. T., Borgdorff, M. W., & Verver, S. (2009) · PubMed · Cited by 30
U. S. Veterans Administration-Armed Forces Cooperative Study on the Chemotherapy of Tuberculosis
Falk, A. (1965) · American Review of Respiratory Disease · doi:10.1164/arrd.1965.91.1.6 · Cited by 30
Loeffler, A. M. (2003) · Seminars in Respiratory Infections · doi:10.1053/s0882-0546(03)00071-9 · Cited by 30
Self-citationPalazzo, R., Spensieri, F., Massari, M., Fedele, G., Frasca, L., Carrara, S., Goletti, D., & Ausiello, C. M. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00342-07 · Cited by 29
Identifying the Sources of Tuberculosis in Young Children: A Multistate Investigation
Sun, S. J., Bennett, D., Flood, J., Loeffler, A. M., Kammerer, S., & Ellis, B. A. (2002) · Emerging infectious diseases · doi:10.3201/eid0811.020419 · Cited by 28 · cited 1×
“While it is tempting to avoid culture collection from the child contact when a putative source case is identified (especially when susceptibility results are already available), prior case series indicate that 2%–10% of children have susceptibility patterns that differ from the presumed source case [168] and more rece…”
ResultSelf-citationAssessment by meta-analysis of interferon-gamma for the diagnosis of tuberculous peritonitis
Su, S.-B. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1645 · Cited by 27 · cited 1×
“A meta-analysis of 6 studies estimated that the sensitivity and specificity of an elevated free IFN-γ level in peritoneal fluid are 93% and 99%, respectively [205].”
BackgroundSloutsky, A., Han, L., & Werner, B. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1547-1551.2004 · Cited by 27 · cited 1×
“As an example, the presence of inhibitors can cause false-negative results for some NAATs [142] and, therefore, if a specimen has a positive AFB smear result and a negative NAAT result, evaluation of the sample for the presence of inhibitors should be considered if the NAAT being used is subject to inhibition.”
BackgroundBienek, D. R., & Chang, C.-C. (2009) · PubMed · Cited by 26
Susceptibility Test Methods: Mycobacteria, Nocardia , and Other Actinomycetes
Woods, G. L., Lin, S.-Y. G., & Desmond, E. P. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch76 · Cited by 25
Self-citationDaley, C. L., Reves, R. R., Beard, M. A., Boyle, J., Clark, R. B., Beebe, J. L., Catanzaro, A., Chen, L., Desmond, E. P., Dorman, S. E., et al. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/670635 · Cited by 23 · cited 1×
“Such studies have not yielded useful criteria that can be used to distinguish Mtb infection from a false-positive result [119].”
BackgroundSelf-citationRisk factors for drug-resistant tuberculosis among non-US-born persons in New York City.
Clark, C. M., Li, J., Cr, D., & Ss, M. (2005) · PubMed · Cited by 23
Fiberbronchoscopy In Smear-Negative Miliary Tuberculosis
Pant, K., Chawla, R., Mann, P. S., & Jaggi, O. P. (1989) · CHEST Journal · doi:10.1378/chest.95.5.1151 · Cited by 22
Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts: Table 1—
Richeldi, L., Bergamini, B. M., & Vaienti, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00014508 · Cited by 22
Self-citationMolecular Epidemiology: A Tool for Understanding Control of Tuberculosis Transmission
Daley, C. L. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.02.005 · Cited by 22 · cited 1×
“Genotyping is useful in detecting false-positive results due to confirming laboratory cross-contamination [234, 235], investigating outbreaks of TB (both detecting unsuspected outbreaks and confirming suspected outbreaks) [236], evaluating contact investigations [237], and determining whether new episodes of TB are du…”
BackgroundSelf-citationDiagnosis of Tuberculous Meningitis
Monteyne, P., & Sindic, C. (1961) · BMJ · doi:10.1136/bmj.1.5235.1305 · Cited by 21
Reichman, L. B., & Hershfield, E. S. (2000) · CRC Press eBooks · doi:10.1201/9780824745301 · Cited by 21
Kimerling, M. E., Benjamin, W. H., Lok, K. H., Curtis, G., & Dunlap, N. E. (1998) · PubMed · Cited by 20
Mancuso, J. D., Tribble, D. R., Mazurek, G. H., Li, Y., Olsen, C. H., Aronson, N., Geiter, L. J., Goodwin, D., & Keep, L. W. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir321 · Cited by 19 · cited 1×
“tions, discordant tests are likely to be false positives [61, 111].”
BackgroundSelf-citationBreese, P. E., Burman, W. J., Hildred, M. V., Stone, B., Wilson, M. L., Yang, Z., & Cave, M. D. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1213-teocil · Cited by 16
The role of molecular epidemiology in contact investigations: a US perspective.
Daley, C. L., & Kawamura, L. M. (2003) · PubMed · Cited by 15
Self-citation(2002) · PubMed · Cited by 12
Steiner, M., Zimmerman, R. A., Park, B. H., Shirali, S. R., & Schmidt, H. (1968) · PubMed · doi:10.1164/arrd.1968.98.2.201 · Cited by 12
Sauzullo, I., Mengoni, F., Lichtner, M., Rossi, R., Massetti, A. P., Mastroianni, C. M., & Vullo, V. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.08.015 · Cited by 11
Fiberoptic bronchoscopy in diagnosis of patients with suspected active pulmonary tuberculosis.
Wongthim, S., Udompanich, V., Limthongkul, S., Charoenlap, P., & Nuchprayoon, C. (1989) · PubMed · Cited by 11
Interferon-γ release assay tests to rule out active tuberculosis
Janssens, J.-P. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042807 · Cited by 9
FALK, A. (1965) · PubMed · doi:10.1164/arrd.1965.91.6.823 · Cited by 9 · cited 1×
“As an example, an observational study that excluded patients with tuberculous meningitis found that mortality due to disseminated TB fell from 100% to <5% with the introduction of isoniazid-based antimicrobial regimens [192].”
ResultGerogianni, I., Papala, M., Klapsa, D., Zinzaras, E., Petinaki, E., & Gourgoulianis, K. (2007) · Respirology · doi:10.1111/j.1440-1843.2007.01188.x · Cited by 8
Marquez, L., Feske, M. L., Teeter, L. D., Musser, J. M., & Graviss, E. A. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318266b6c4 · Cited by 7 · cited 1×
“In contrast, no discordance was found between pediatric TB cases and their presumed source cases from 2000 to 2004 in Houston [171].”
ResultChou, C., Hsu, H., Lee, L., Hsueh, P., & Luh, K. (2009) · PubMed · Cited by 6
Diagnosis of Tuberculous Meningitis
Azar, J. E. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.4.697 · Cited by 3
Tan, C., Lai, C., Liao, C., Chou, C., Hsu, H., Huang, Y., & Hsueh, P. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02577.x · Cited by 2
Research works printed but not linked: 8
- World Health Organization, 2015, Global tuberculosis report 2015
- T-SPOT.TB: an aid in the diagosis of tuberculosis infection; package insert for in vitro diagnositic use
- Perez, 2005, Impact of screening for latent TB before initiating anti-TNF therapy in North America and Europe, Ann Rheum Dis, 64, 265
- US Food and Drug Administration, 2008, Medical devices: T-SPOT-TB—P070006
- Forbes, 2008, Laboratory detection and identification of mycobacteria; approved guideline
- Francis J. Curry National Tuberculosis Center and California Department of Public Health, 2008, Drug-resistant tuberculosis: a survival guide for clinicians
- World Health Organization, 2008, Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB)
- Ena, 1990, The usefulness and limitations of adenosine deaminase in the diagnosis of tubercular pleurisy. A meta-analytical study [in Spanish], Med Clin (Barc), 95, 333
Cited by
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
“A cytokine release assay analogous to the tuberculosis IFNg release assay is a possibility (Lewinsohn et al., 2017; Murugesan et al., 2020; Petrone et al., 2020), as are plasmaCXCL10 (Rydyznski Moderbacher et al.”
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethodThe global prevalence of latent tuberculosis: A systematic review and meta-analysis
Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00655-2019 · Cited by 547
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., Cattamanchi, A., Cegielski, J. P., Chen, L., Daley, C. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201909-1874st · Cited by 462
“The WHO-recommended standardized shorter-course 9-to 11-month regimen for MDR-TB was estimated by the guidelines committee to have minimal desirable effects (on treatment success, mortality, culture conversions) and small to moderate undesirable effects (adverse events, the use of drugs for which there is documented o…”
InfluentialSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“The figures for free IFN-λ were ≥89% and ≥97% for sensitivity and specificity, respectively [121].”
BackgroundMethod
Metadata
- Authors
- Lewinsohn, D. M., Leonard, M. K., LoBue, P. A., Cohn, D. L., Daley, C. L., Desmond, E., Keane, J., Lewinsohn, D. A., Loeffler, A. M., Mazurek, G. H., O’Brien, R. J., Pai, M., Richeldi, L., Salfinger, M., Shinnick, T. M., Sterling, T. R., Warshauer, D. M., & Woods, G. L.
- Affiliations
- Oregon Health & Science University (US)
- Emory University School of Medicine and
- Centers for Disease Control and Prevention (US)
- Denver Public Health (US)
- National Jewish Health (US)
- California Department of Public Health (US)
- St. James's Hospital (IE)
- Francis J. Curry International TB Center, San Francisco, California;
- FIND (CH)
- McGill University (CA)
- University of Southampton (GB)
- Vanderbilt University (US)
- Wisconsin State Laboratory of Hygiene, Madison, and
- University of Arkansas for Medical Sciences (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-12-08
- Volume
- 64
- Issue
- 2
- Pages
- e1-e33
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC5504475
- OpenAlex
- W2559832962
- Cited by
- 992
- References
- 246
- Citations by year
- 2026: 65 · 2025: 81 · 2024: 91 · 2023: 101 · 2022: 115 · 2021: 142 · 2020: 133 · 2019: 110 · 2018: 96 · 2017: 55 · 2016: 1
- FWCI
- 80.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, latent tuberculosis infection, pulmonary tuberculosis, extrapulmonary tuberculosis, Mycobacterium tuberculosis, diagnostic testing, children, adults
- MeSH terms
- Adult, Age Factors, Child, Humans, Mycobacterium tuberculosis, Tuberculosis, Tuberculosis, Pulmonary, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.